Quanta BioSciences Achieves Milestone with the FDA Clearance of the CDC Influenza IVD kit which utilizes the Quanta 1-Step RT-qPCR technology

GAITHERSBURG, Md., July 8, 2013

Quanta BioSciences today announced that the CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel Kit, which utilizes QUANTA Biosciences' qScript One-Step qRT-PCR Low ROX, has received FDA clearance.

This announcement follows the emergency use authorization granted by the FDA on April 22, 2013 for use of the same kit for characterization and detection of H7N9 influenza.